Previous Studies funded by the HHV-6 Foundation

Human herpesvirus 6B induced hypomethylation on chromosome 17p13.3 Elin Enghdahl, Karolinska Institute
HHV-6 infection in patients after allogeneic HSCT Raffaella Greco, MD, San Raffaele Scientific Institute, Milano, Italy
ciHHV-6 activation in response to drugs Bhupesh Prusty, PhD, University of Würzburg
Chromosomal integration in HSCT patients Vicki Boussiotis, MD. PhD, Beth Israel Deasoness Medical Center
HHV-6 in Gliomas Nanjing Medical University
Exploration of ciHHV6 in the Generation Scotland dataset Ruth Jarrett, University of Glasgow
HHV-6 in Post Transplant Limbic Encephalitis Joshua Hill, Fred Hutchinson Cancer Research Center
Detection of HHV-6 in Children with Epilepsy Tobias Loddenkemper, MD, Boston Children’s Hospital
HHV-6A genomic integration in Zambia and infant development Gompels, London School of Hygiene & Tropical Medicine
HHV-6 infection and ciHHV-6 in cord blood transplantation Anoma Nellore, Beth Israel Deaconness Medical Center
HHV-6 and parvovirus B19 co-infection in a wide variety of human diseases and cancer Jacqueline Hobbs, University of Florida College of Medicine
HHV-6 genomic integration in Zambia and infant development Ursula Gompels, University of London School of Hygiene and Tropical Medicine
HHV-6 in Hodgkin’s Lymphoma Ruth Jarrett, University of Glasgow Center for Virus Research
Efficacy of antiviral drug treatment of HHV-6 infection Peter Medveczky, University of South Florida
Development of Humanized Rag2-/-gc-/- Mice as a model of HHV-6A infection Bradford Berges, Brigham Young University
The contribution of neuroinflammatory responses to HHV-6B/HHV-7 infection in the pathogenesis of mesial temporal lobe epilepsy Jin Mei Li & Dong Zhou, West China Hospital & Sichuan University
HHV-6 in adult and pediatric brain tumors Michael Scheurer, Dan L. Duncan and Texas Children’s Cancer Centers, Baylor College of Medicine
Prevalence and significance of ciHHV-6 infection in liver transplant recipients Raymund Razonable, Division of Transplant and Infectious Diseases, Mayo Clinic
Study of Chromosomally Integrated HHV-6 Subjects Prior and Post Valcyte Treatment Daniel Peterson, Simmaron Research
The role of HHV-6 in pediatric convulsions of unknown cause Ankrah Lennox-Mac, Department of Microbiology, University of Ghana Medical School
Development of an improved TCID50 assay for HHV-6A Rasmus Gustafsson, The Karolinska Institute, Sweden
Human Herpesvirus-6, dendritic cells and TH17 Anshu Agrawal, University of California at Irvine
The role of U94/rep gene and TTAGGG telometric repeats of HHV-6 in integration in human chromosomes Peter Medveczky, University of South Florida
The Functional Characterization of HHV-6/U94 Gene Product Louis Flamand, Centre Hospital University de Quebec
Anti-HHV-6 activity of the broad antiinfective drug artesunate: investigation of the mode of action Jens Milbradt & Manfred Marschall, Institute for Clinical and Molecular Virology, Erlangen Medical Center, Germany
Adoptive T cell Immunotherapy to Prevent or Treat HHV-6 Ulrike Gerdeman, Center for Cell & Gene Therapy, Baylor University
XMRV, HHV-6, EBV & Endogenous retroviruses in patients with CFS Brigitte Huber, Tufts University
2008 and Beyond
HHV-6 Specific CD8+ T cell Responses Sudhir Gupta, MD, PhD, MACP University of California Irvine, California USA
Development of a Variant-specific, Calibrated Real-time PCR Assay for the Absolute Quantification of HHV-6A and B Nucleic Acids in Clinical Samples Mauro S. Malnati, MDSan Raffaele Scientific InstituteMilan, Italy USA
The Human Herpesvirus 6A U45 Gene Product: Role in Immune Dysfunction Marshall Williams, PhDOhio State University, USA
Variant Specific PCR ELISA Yi-Wei Tang, MD, PhDVanderbilt University, USA
Determination of the chromosomal integration of the HHV-6 virus in highly seropositive Chronic Fatigue Syndrome patients Daniel L. Peterson, MD, Sierra Internal Medicine, Nevada, USA
The role of chronic immune stimulation by active herpesvirus 6 (HHV-6) infection/coinfections in immune dysfunction and development of lymphoma Daniel L. Peterson, MD, Sierra Internal Medicine, Nevada, USA
Investigation of inhibitory effects of the multipotent drug Artesunate against HHV-6 Manfred Marschall, PhDUniversität Erlangen-Nürnberg, Germany
Creation of a humanized CD46 mouse model for HHV-6 infection Claude P. Genain, MDCalifornia Pacific Medical Center Research Institute, San Francisco USA
Study of HHV-6 & EBV in patients with CNS Dysfunction and long-standing fatigue Jose Montoya, MDStanford University, USA
Use of recombinant viral proteins for the identification of active HHV-6 infection by serological assays. Louis Flamand, PhD,Universite Laval, Quebec, Canada, USA
Cloning the HHV-6 A and B genome for the identification of genes responsible for pathogenicity Peter Medveczky, MD, University of South Florida, College of Medicine, USA
A study of incidence of ciHHV-6 in children with congenital infection of HHV-6 Carolyn Hall, MDUniversity of Rochester
Study of HHV-6B in Mesial Temporal Lobe Epilepsy Nihal De Lanerolle, MD, PhDYale University, MD, PhD
ciHHV-6 FISH analysis Peter Ambros, PhDChildren’s Cancer Research Institute
HHV-6 activation of HERV K18 Brigitte Huber, PhdTufts University